ReviewFrontiers in nutrition2025
Beneficial effects of proanthocyanidins on skin aging: a review.
Review in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Botanical and Upcycled Bioactives for Advanced Topical Formulations: Mechanistic Pathways, Cutaneous Delivery, and Sustainability-by-Design.Pharmaceutics · 2026Review
- The Antioxidant Activity of a Prepared Cream Containing Saffron Extract and Grape Seed Extract.BioMed research international · 2026Article
- Proliferative Effect of Proanthocyanidins on HGF-1 and HPDLF Cells: An In Vitro Study.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin aging is a gradual physiological process influenced by both intrinsic and environmental factors and is characterized by the appearance of wrinkles, pigmentation, reduced elasticity, dryness, and vascular changes. In recent years, interest in the use of natural bioactive compounds to mitigate skin aging has increased, reflecting the global shift toward safer, sustainable, and health-conscious skincare solutions. Proanthocyanidins (PCs), a class of polyphenolic compounds derived from plant sources, exhibit strong antioxidant, anti-inflammatory, and antipigmentation properties. These compounds have considerable potential for enhancing the structure and function of aged skin by reducing oxidative stress, promoting collagen and elastin synthesis, alleviating the skin inflammatory response, and inhibiting pigmentation. Despite their promising therapeutic value, the efficacy of PCs can be compromised by their environmental instability and low bioavailability. Advances in encapsulation techniques and combination formulations have shown promise in enhancing the stability and delivery efficiency of PCs, thereby improving their performance in antiaging applications. In conclusion, PCs offer a scientifically grounded and sustainable approach for addressing skin aging. Their integration into dermatological products represents an innovative and eco-conscious strategy for developing next-generation skincare solutions with broad health and consumer benefits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.